High intensity focused ultrasound (HIFU) therapy kills cancer cells with high frequency sound waves. It can treat only a single tumor or a part of a large tumor and cannot be used to treat widespread tumors. Thus, the HIFU therapy is not suitable for the treatment of malignant tumor. This therapy is a novel, emergent and practices ultrasound waves that propagate through tissue media as energy carriers. HIFU therapy is a completely non-invasive technology that has great potential of tumor ablation, hemostasis, thrombolysis as well as targeted drug/gene delivery.
High Intensity Focused Ultrasound Therapy Market contains market size and forecasts of High Intensity Focused Ultrasound (HIFU) Therapy in Global, including the following market information:
- Global High Intensity Focused Ultrasound (HIFU) Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global High Intensity Focused Ultrasound (HIFU) Therapy market was valued at 85 million in 2021 and is projected to reach US$ 254.4 million by 2028, at a CAGR of 16.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Therapeutic Ultrasound Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of High Intensity Focused Ultrasound (HIFU) Therapy include EDAP TMS, SonaCare Medical, Theraclion, Chongqing Haifu Medical Technology, Koninklijke Philips, Insightec and Alpinion Medical Systems, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the High Intensity Focused Ultrasound (HIFU) Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global High Intensity Focused Ultrasound (HIFU) Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global High Intensity Focused Ultrasound (HIFU) Therapy Market Segment Percentages, by Type, 2021 (%)
- Therapeutic Ultrasound
- Hemostasis
Global High Intensity Focused Ultrasound (HIFU) Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global High Intensity Focused Ultrasound (HIFU) Therapy Market Segment Percentages, by Application, 2021 (%)
- Diagnostic Centers
- Hospitals
- Research Centers
Global High Intensity Focused Ultrasound (HIFU) Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global High Intensity Focused Ultrasound (HIFU) Therapy Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies High Intensity Focused Ultrasound (HIFU) Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies High Intensity Focused Ultrasound (HIFU) Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- EDAP TMS
- SonaCare Medical
- Theraclion
- Chongqing Haifu Medical Technology
- Koninklijke Philips
- Insightec
- Alpinion Medical Systems
Industry Market Size
